Advertisement
Advertisement

KAPA

KAPA logo

Kairos Pharma, Ltd.

0.56
USD
Sponsored
+0.01
+0.97%
May 08, 15:51 UTC -4
Closed
exchange

After-Market

0.56

0.00
+0.18%

Kairos Pharma, Ltd. Profile

About

Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company. It focused on developing a diversified pipeline of cutting-edge oncology therapeutics born from structural biology to reverse cancer drug resistance and the inhibitory effects of cancer on the immune system. Kairos Pharma Ltd. is based in Los Angeles, California.

Info & Links

CEO

John S. Yu

Headquarters

2355 WESTWOOD BLVD., 139
LOS ANGELES, CA 90064, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.kairospharma.com

Auditor

Weinberg & Company P.A.

Share holders

--

Employees

4

Kairos Pharma, Ltd. Statistics

Valuation Measures

Market Capitalization2

12.01M

Enterprise Value

7.52M

Enterprise Value/EBITDA(ttm)

-2.32

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.84

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-80.30%

Return on Invested Capital(ttm)

-80.17%

Return on Assets(ttm)

-74.58%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-3.24M

Net Income Available to Common(ttm)

-5.45M

Diluted EPS(ttm)

-0.30

Share Statistics

Beta (5Y Monthly)

1.97

52-Week Change

-25.83%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

21.41M

Dividend Yield

0.00%

Float4

12.93M

% Held by Insiders

39.60%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

5.34M

Total Cash Per Share(mrq)

0.25

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

16.56%

Quick Ratio(mrq)

27.07%

Book Value Per Share(mrq)

0.37

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.12

Free Cash Flow(ytd)

-2.36M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement